Literature DB >> 22346420

Estimation of the secondary attack rate for delta hepatitis coinfection among injection drug users.

C Poulin1, T Gyorkos, L Joseph.   

Abstract

The secondary attack rate for delta hepatitis coinfection was estimated among a cluster of injection drug users (IDUs). The infections occurred during an epidemic of hepatitis B in a rural area of Nova Scotia in 1988 and 1989. Six IDUs formed a cluster of delta hepatitis coinfections, representing the first reported outbreak of delta hepatitis in Canada. Contact-tracing was used to identify a cluster of 41 IDUs potentially exposed to delta hepatitis. The index case of delta hepatitis coinfection was presumed to have led to five secondary cases. The secondary attack rate was estimated to be 13.2% (95% confidence interval 0.044 to 0.281). The estimated secondary attack rate may be a useful predictor of disease due to delta hepatitis coinfection in similar IDU populations.

Entities:  

Keywords:  Delta hepatitis; Hepatitis D coinfection; Injection drug use; Secondary attack rate

Year:  1993        PMID: 22346420      PMCID: PMC3250805          DOI: 10.1155/1993/539613

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  15 in total

1.  The serology of delta hepatitis and the detection of IgM anti-HD by EIA using serum derived delta antigen.

Authors:  A G Shattock; M Morris; K Kinane; C Fagan
Journal:  J Virol Methods       Date:  1989-03       Impact factor: 2.014

2.  Prevalence of hepatitis delta (delta) virus infection. A seroepidemiologic study.

Authors:  K M DeCock; B Jones; S Govindarajan; A G Redeker
Journal:  West J Med       Date:  1988-03

3.  Worldwide epidemiology and modes of transmission of delta hepatitis.

Authors:  A R Zanetti; A Ponzetto; B Forzani; C Hele
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

4.  Infection with delta agent in Sweden: introduction of a new hepatitis agent.

Authors:  B G Hansson; T Moestrup; A Widell; E Nordenfelt
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

5.  Experimental transmission of the delta agent to chimpanzees.

Authors:  R H Purcell; J L Gerin; M Rizzetto; A Ponzetto; F Bonino; W T London
Journal:  Prog Clin Biol Res       Date:  1983

6.  Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts.

Authors:  L A Lettau; J G McCarthy; M H Smith; S C Hadler; L J Morse; T Ukena; R Bessette; A Gurwitz; W G Irvine; H A Fields
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

7.  Antibody to hepatitis D virus (delta agent) in selected Manitoba residents, 1974-1986.

Authors:  C Hannan; L Sekla; B Schacter; W Stackiw
Journal:  Clin Invest Med       Date:  1988-06       Impact factor: 0.825

8.  Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador.

Authors:  S Ratnam; C B Head; R W Butler
Journal:  CMAJ       Date:  1986-04-15       Impact factor: 8.262

Review 9.  Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations.

Authors:  F B Hollinger
Journal:  Am J Med       Date:  1989-09-04       Impact factor: 4.965

10.  The prevalence of antibody to delta virus in western Canada.

Authors:  H H Cheng; D Q Wang; G Y Minuk; C M Anand; T C Stowe; K A Buchan
Journal:  Clin Invest Med       Date:  1986       Impact factor: 0.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.